hypericin has been researched along with ATLL in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypericin (HY) is a new-type of photosensitizer in the context of photodynamic therapy (PDT) due to its excellent photosensitizing properties and anti-tumor activities." | 1.51 | Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription. ( Cheng, W; Shao, L; Wang, Y; Wang, Z; Xu, L; Yi, K; Zhang, X; Zhang, Y; Zhao, T, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, L | 1 |
| Zhang, X | 1 |
| Cheng, W | 1 |
| Wang, Y | 1 |
| Yi, K | 1 |
| Wang, Z | 1 |
| Zhang, Y | 1 |
| Shao, L | 1 |
| Zhao, T | 1 |
1 other study available for hypericin and ATLL
| Article | Year |
|---|---|
Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Human T-lymphotropic vi | 2019 |